USV Biologics

USV Biologics appears to be the biologics and biosimilars division of USV Private Limited, an Indian pharmaceutical and biotechnology company headquartered in Mumbai. The broader USV group markets branded and generic medicines with strong franchises in diabetes and cardiology, while its biologics activities focus on biosimilars and related manufacturing capabilities. Public company materials indicate USV has established biologics R&D capabilities, launched a biosimilar pegfilgrastim product internationally, and entered the insulin market in India with an insulin aspart biosimilar. USV also highlights vertically integrated manufacturing, niche product development in biosimilars and synthetic peptides, and broad international reach across more than 65 countries. Because "USV Biologics" is presented mostly as a division rather than a separately incorporated entity, company-level information is best understood as pertaining to USV Private Limited unless otherwise specified.